Company
Biomatter
We build impossible enzymes for your visionary products.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Customers
- leading companies across diverse industries
Claim, correct or request removal
Record updated 17 September 2026
About
The Intelligent Architecture™ platform addresses the limitations of legacy protein engineering approaches and unlocks new horizons for the digital design of new enzymes.
Funding snapshot
- Latest round
- Seed2024-08-05
Funding rounds
- Seed
- 2024-08-05
Products
- Other
- Intelligent Architecture™
- Other
- LYNX Enzyme Optimization™
Loading relationship preview